Target Name: MTERF4
NCBI ID: G130916
Review Report on MTERF4 Target / Biomarker Content of Review Report on MTERF4 Target / Biomarker
MTERF4
Other Name(s): Mitochondrial transcription termination factor 4, transcript variant 1 | MTERF domain-containing protein 2 | Transcription termination factor 4, mitochondrial | mitochondrial transcription termination factor 4 | mTERF domain-containing protein 2 | MTERF4 variant 1 | Transcription termination factor 4, mitochondrial (isoform 1) | mTERF domain-containing protein 2 processed | MTERFD2 | Mitochondrial transcription termination factor 4 | MTEF4_HUMAN

Regulation of Mitochondrial Genes

Mitochondrial Transcription Termination Factor 4 (MTERF4) is a non-coding RNA molecule that plays a crucial role in regulating gene expression in the mitochondria. MTERF4 is a key regulator of mitochondrial DNA replication and helps ensure the accuracy of gene expression by regulating the terminal RNA structure. MTERF4 is also involved in the regulation of mitochondrial protein synthesis and has been implicated in a number of cellular processes, including cell growth, apoptosis, and metabolism.

MTERF4 is a protein that is expressed in a variety of tissues, including muscle, heart, and brain. It is primarily localized to the mitochondria, where it plays a critical role in regulating gene expression. MTERF4 is a key regulator of mitochondrial DNA replication and helps ensure the accuracy of gene expression by regulating the terminal RNA structure. MTERF4 is also involved in the regulation of mitochondrial protein synthesis and has been implicated in a number of cellular processes, including cell growth, apoptosis, and metabolism.

One of the key functions of MTERF4 is its role in regulating the terminal RNA structure. MTERF4 is involved in the formation of a complex with the protein Transcription factors, which helps to ensure the accuracy of RNA secondary structure. This is important for the regulation of gene expression, as the structure of the RNA molecule can influence how it is translated into protein.

MTERF4 is also involved in the regulation of mitochondrial DNA replication. MTERF4 plays a key role in the regulation of DNA synthesis, as well as the correction of errors that occur during DNA replication. This is important for the maintenance of genetic accuracy and for the regulation of cell growth.

In addition to its role in regulating DNA replication, MTERF4 is also involved in the regulation of apoptosis. MTERF4 has been shown to play a role in the regulation of cell death, and is thought to play a key role in the apoptotic process. This is important for the regulation of tissue homeostasis and for the maintenance of cellular order.

MTERF4 is also involved in the regulation of metabolism. MTERF4 plays a role in the regulation of mitochondrial protein synthesis and has been shown to play a key role in the regulation of cellular metabolism. This is important for the regulation of energy production and for the maintenance of cellular homeostasis.

In conclusion, MTERF4 is a non-coding RNA molecule that plays a crucial role in regulating gene expression in the mitochondria. MTERF4 is involved in the regulation of mitochondrial DNA replication, the regulation of apoptosis, and the regulation of metabolism. These functions make MTERF4 an attractive drug target and a potential biomarker for a variety of diseases.

Protein Name: Mitochondrial Transcription Termination Factor 4

Functions: Regulator of mitochondrial ribosome biogenesis and translation. Binds to mitochondrial ribosomal RNAs 16S, 12S and 7S and targets NSUN4 RNA methyltransferase to the mitochondrial large ribosomal subunit (39S)

The "MTERF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTERF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MTF1 | MTF2 | MTFMT | MTFP1 | MTFR1 | MTFR1L | MTFR2 | MTG1 | MTG2 | MTHFD1 | MTHFD1L | MTHFD2 | MTHFD2L | MTHFD2P7 | MTHFR | MTHFS | MTHFSD | MTIF2 | MTIF3 | MTLN | MTM1 | MTMR1 | MTMR10 | MTMR11 | MTMR12 | MTMR14 | MTMR2 | MTMR3 | MTMR4 | MTMR6 | MTMR7 | MTMR8 | MTMR9 | MTMR9LP | MTND1P11 | MTND1P23 | MTND1P3 | MTND1P33 | MTND2P21 | MTND2P28 | MTND4P10 | MTND4P12 | MTND4P17 | MTND4P22 | MTND4P24 | MTND4P28 | MTND4P29 | MTND5P10 | MTND5P16 | MTND5P19 | MTND5P20 | MTND5P31 | MTND5P8 | MTND6P14 | MTND6P4 | MTNR1A | MTNR1B | MTO1 | MTOR | mTOR complex 1 | mTOR complex 2 | MTPAP | MTPN | MTR | MTRES1 | MTREX | MTRF1 | MTRF1L | MTRF1LP2 | MTRFR | MTRNR2L1 | MTRNR2L10 | MTRNR2L11 | MTRNR2L12 | MTRNR2L13 | MTRNR2L2 | MTRNR2L3 | MTRNR2L4 | MTRNR2L5 | MTRNR2L6 | MTRNR2L7 | MTRNR2L8 | MTRNR2L9 | MTRR | MTSS1 | MTSS2 | MTTP | MTURN | MTUS1 | MTUS1-DT | MTUS2 | MTUS2-AS1 | MTVR2 | MTX1 | MTX2 | MTX3 | mu-Calpain (calpain 1) | MUC1 | MUC12 | MUC13